Coronavirus (COVID-19)
Learn more
May 09, 2017
Sponsor: Astellas Pharma Global Development, Inc.
Number: Trumpet-ONC-MA-1004
The purpose of this study is to describe patterns of care in CRPC (Castration-Resistant Prostate Cancer) patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.
This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment, changes for CRPC, as well as describe clinical outcomes based on patient characteristics.
Who’s eligible:
Available at: Backus Hospital- Eastern Connecticut Hematology and Oncology.
Referral Line: 860.972.4700
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.